Harold E. Selick, Director at PDL BIOPHARMA, INC. (PDLI), bought 5,900 shares at $8.08 ($48K) on 2014-11-26, disclosed to the SEC on 2014-11-28.
Open-market purchase of $48k PDLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.08 | 100 | $808 | 1.7% |
| 2 | $8.08 | 300 | $2K | 5.1% |
| 3 | $8.08 | 2,000 | $16K | 33.9% |
| 4 | $8.08 | 2,110 | $17K | 35.8% |
| 5 | $8.09 | 1,390 | $11K | 23.6% |
| Total | $8.08 avg | 5,900 |
| $48K |
| 100% |
| Filing → |
| THLD | BUY | 2011-03-15 | $100K | — | Filing → |
| THLD | BUY | 2009-10-06 | $97K | — | Filing → |
| THLD | BUY | 2009-06-05 | $30K | — | Filing → |